Serina Therapeutics, Inc. (SER) Financial Statements (2026 and earlier)

Company Profile

Business Address 601 GENOME WAY
HUNTSVILLE, AL 35806
State of Incorp. AL
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3,0563,672345645584527
Cash and cash equivalent3,0563,672345645584527
Restricted cash and investments    695634 
Receivables   57425326
Prepaid expense409594    
Other current assets30977    
Other undisclosed current assets2,3061,3333521,1099911,430
Total current assets:6,0805,6767542,4532,2342,283
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization  86    
Operating lease, right-of-use asset377461    
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization465501    
Long-term investments and receivables   10,554   
Accounts and financing receivable, after allowance for credit loss   10,554   
Intangible asset, including goodwill, after accumulated amortization   6077388701,592
Intangible asset, excluding goodwill, after accumulated amortization   6077388701,592
Prepaid expense29     
Deposits noncurrent assets     5050
Restricted cash and investments   5050  
Total noncurrent assets:8711,04811,2117889201,642
TOTAL ASSETS:6,9516,72411,9653,2413,1543,925
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:3,1382,1732,1761,0347711,656
Employee-related liabilities✕✕✕✕✕212228
Accounts payable1,9317441,413568193761
Accrued liabilities1,2071,429529273  
Other undisclosed accounts payable and accrued liabilities   234193366667
Deferred revenue      275
Debt   3,6727,646 436
Other liabilities337193    
Due to related parties✕✕✕✕1417,1401,960
Other undisclosed current liabilities88 661,2571,0561,030
Total current liabilities:3,5632,3665,91410,0788,9675,357
Noncurrent Liabilities
Long-term debt and lease obligation2,946 69310,478  
Long-term debt, excluding current maturities2,946 69310,478  
Liabilities, other than long-term debt196268  6,0623,964
Deferred revenue      64
Due to related parties✕✕✕✕ 6,0623,900
Operating lease, liability196268    
Other undisclosed noncurrent liabilities2833,582    
Total noncurrent liabilities:3,4253,85069310,4786,0623,964
Total liabilities:6,9886,2166,60720,55615,0299,321
Equity
Equity, attributable to parent, including:(37)6415,469(17,212)(11,832)(5,116)
Preferred stock4,940     
Common stock11 444
Common stock held by subsidiary   (250) (3,248) 
Additional paid in capital58,53644,958136,48298,99493,91291,810
Accumulated other comprehensive income (loss)(14)    143
Accumulated deficit(63,500)(44,318)(131,013)(116,210)(105,748)(97,073)
Other undisclosed equity, attributable to parent   250 3,248 
Equity, attributable to noncontrolling interest  (133)(111)(103)(43)(280)
Total equity:(37)5085,358(17,315)(11,875)(5,396)
TOTAL LIABILITIES AND EQUITY:6,9516,72411,9653,2413,1543,925

Income Statement (P&L) ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues13056142341441,868
Cost of revenue   (40)(13)(19)(158)
Gross profit:13056102211251,710
Operating expenses(24,152) (10,062)(6,996)(8,164) 
Other undisclosed operating income   73 106 
Operating income (loss):(24,022)56(9,887)(6,975)(7,933)1,710
Nonoperating income (expense)4,8255,841(4,924)(3,547)(649) 
Other nonoperating income512281113448 
Interest and debt expense(213)(526)(4,900)(3,335)437(487)
Other undisclosed loss from continuing operations before equity method investments, income taxes      (12,349)
Income (loss) from continuing operations before equity method investments, income taxes:(19,410)5,371(19,711)(13,857)(8,145)(11,126)
Other undisclosed income (loss) from continuing operations before income taxes213(16,512)34,51124,357(540) 
Income (loss) from continuing operations before income taxes:(19,197)(11,141)14,80010,500(8,685)(11,126)
Income tax expense(18)     
Other undisclosed income (loss) from continuing operations   (21,022)8,688 
Income (loss) from continuing operations:(19,215)(11,141)14,800(10,522)3(11,126)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(100)(11,126)
Loss from discontinued operations     (103) 
Other undisclosed net loss  (66)(29,611) (8,585) 
Net loss:(19,215)(11,207)(14,811)(10,522)(8,685)(11,126)
Net income attributable to noncontrolling interest3366860 111
Other undisclosed net income attributable to parent     10150
Net loss attributable to parent:(19,182)(11,141)(14,803)(10,462)(8,675)(10,865)
Preferred stock dividends and other adjustments(254)     
Undistributed earnings (loss) allocated to participating securities, basic  (66)    
Other undisclosed net income available to common stockholders, basic  66  17,254 
Net income (loss) available to common stockholders, diluted:(19,436)(11,141)(14,803)(10,462)8,579(10,865)

Comprehensive Income ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(19,215)(11,207)(14,811)(10,522)(8,685)(11,126)
Other comprehensive loss    (10,462)(8,818)(10,791)
Other undisclosed comprehensive loss(14)     
Comprehensive loss:(19,229)(11,207)(14,811)(20,984)(17,503)(21,917)
Comprehensive income, net of tax, attributable to noncontrolling interest3366860 111
Other undisclosed comprehensive income, net of tax, attributable to parent    10,4028,67510,904
Comprehensive loss, net of tax, attributable to parent:(19,196)(11,141)(14,803)(10,522)(8,828)(10,902)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: